If your symptoms persist or worsen, seek further advice from your healthcare provider
5 WARNINGS AND PRECAUTIONS 5.1 Risk of Thyroid C-Cell Tumors In mice and rats, semaglutide caused a dose-dependent and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure at clinically relevant plasma exposures [see Nonclinical Toxicology (13.1)]
Keep your prescription label readily available in case security asks for verification
While semaglutide has demonstrated cardiovascular benefits in clinical trials, individual patients may experience complications unrelated to the medication that require assessment
Trava Health's telehealth weight loss program in Appleton delivers personalized care, making it easier for patients to reach and maintain their weight loss goals while improving their overall quality of life
The STEP 1 trial showed semaglutide produced average weight loss of 14.9% of body weight over 68 weeks, compared with 2.4% with placebo